Study: Genovese 2010, Science

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

Citation

Genovese G, Friedman DJ, Ross MD, Lecordier L et al (2010). Science. PubMed id 20647424.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Kidney disease, the APOL1 gene and the eGFR race adjustment Tier B moderate

    B African Americans with focal segmental glomerulosclerosis (FSGS) and hypertension-attributed end-stage kidney disease (H-ESKD), and controls (n=not stated in the abstract)

    Genetic association study with lab assays of the APOL1 protein.

    Two independent APOL1 sequence variants were associated with FSGS (odds ratio 10.5, 95% CI 6.0-18.4) and H-ESKD (odds ratio 7.3, 95% CI 5.6-9.5). The variants are common in African chromosomes but absent from European chromosomes, and sit within haplotypes showing positive selection. Only the kidney-disease variants lysed Trypanosoma brucei rhodesiense in vitro; the authors speculate a survival factor against sleeping sickness may have contributed to high kidney disease rates.

    As recorded in this card: Genovese G, Friedman DJ, Ross MD, Lecordier L et al (2010), Science, [primary]

    Note: Odds ratios refer to carrying two risk variants against none in African Americans; the abstract does not give how common two-variant carriers are.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.